UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058197
Receipt number R000066418
Scientific Title A Confirmatory Trial on Acute Stress Recovery Using Combined Vibration and Music Stimulation with Gradually Slowing Tempo
Date of disclosure of the study information 2025/06/30
Last modified on 2025/06/16 18:15:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on Stress Reduction Effects of Combined Vibration and Music Stimulation

Acronym

Vibro-Music Stress Study (VMSS-2)

Scientific Title

A Confirmatory Trial on Acute Stress Recovery Using Combined Vibration and Music Stimulation with Gradually Slowing Tempo

Scientific Title:Acronym

Tempo-Synchronized Vibro-Music Stimulation for Stress Recovery (TSVMSSR)

Region

Japan


Condition

Condition

None (Healthy participants)

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study is to evaluate the effects of gradually slowing tempo synchronized vibration and music stimulation on acute stress recovery in healthy male participants.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in stress indicators (salivary cortisol concentration, VAS, Jikaku-sho Shirabe, and Emotion and Mood Inventory) before and after the intervention under acute stress conditions. Although the study protocol originally specified autonomic nervous system indicators (e.g., HRV) as the primary outcomes, they could not be analyzed due to data quality issues. Therefore, the above indicators were registered and reported as the primary outcomes.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Variable vibration plus music stimulation
Combined vibration and music stimulation synchronized to the participant's heart rate and gradually slowed to 50 bpm, delivered for approximately 4 minutes via headphones and a handheld vibration device.

Interventions/Control_2

Music only
Participants listened to music only for approximately 4 minutes via headphones. Vibration was not delivered, but the vibration device was held.

Interventions/Control_3

Control (no stimulation)
Participants wore headphones and held the vibration device, but received no stimulation for approximately 4 minutes.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

25 years-old <=

Age-upper limit

49 years-old >=

Gender

Male

Key inclusion criteria

- Healthy males aged 25 to 49 years
- Provided written informed consent after full explanation

Key exclusion criteria

History of severe physical illness

History of treatments or use of medications that may influence autonomic nervous function

Discomfort during hearing tests or when wearing headphones

Inability to maintain regular daily routines during the study period

Target sample size

36


Research contact person

Name of lead principal investigator

1st name tomonori
Middle name
Last name motokawa

Organization

POLA Chemical Industries, Inc.

Division name

Frontier Research Center

Zip code

244-0812

Address

560, kasio-cho, totsuka-ku, yokohama, kanagawa, JAPAN

TEL

045-826-7134

Email

motchy.motchy@mail.u-tokyo.ac.jp


Public contact

Name of contact person

1st name tomomi
Middle name
Last name kato

Organization

POLA Chemical Industries, Inc.

Division name

Frontier Research Center

Zip code

244-0812

Address

560, kasio-cho, totsuka-ku, yokohama, kanagawa, JAPAN

TEL

045-826-7134

Homepage URL


Email

k-tomo@pola.co.jp


Sponsor or person

Institute

POLA Chemical Industries, Inc.

Institute

Department

Personal name



Funding Source

Organization

POLA Chemical Industries, Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

POLA Chemical Industries, Inc.

Address

560, kasio-cho, totsuka-ku, yokohama, kanagawa, JAPAN

Tel

045-826-7134

Email

y-miyasaka@pola.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

36

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 05 Month 15 Day

Date of IRB

2021 Year 05 Month 15 Day

Anticipated trial start date

2021 Year 05 Month 16 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 16 Day

Last modified on

2025 Year 06 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066418